ImmunoPET for prostate cancer in the PSMA era: do we need other targets?

被引:0
|
作者
Luca Filippi
Laura Evangelista
Mike M. Sathekge
Orazio Schillaci
机构
[1] Santa Maria Goretti Hospital,Department of Nuclear Medicine
[2] University of Padua,Nuclear Medicine Unit, Department of Medicine (DIMED)
[3] University of Pretoria,Department of Nuclear Medicine
[4] Steve Biko Academic Hospital,Nuclear Medicine Research Infrastructure (NuMeRI)
[5] University Tor Vergata,Department of Biomedicine and Prevention
[6] IRCCS Neuromed,undefined
来源
关键词
ImmunoPET; Prostate cancer; Precision medicine; Castration-resistant prostate cancer; PET/CT; Theranostics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:587 / 596
页数:9
相关论文
共 50 条
  • [41] Prostate-cancer-associated hypercoagulability: do we need to worry about androgen deprivation?
    Saylor, Philip J.
    Fogerty, Annemarie E.
    LANCET ONCOLOGY, 2010, 11 (05): : 406 - 407
  • [42] Radiotherapy for localised prostate cancer - How many modalities do we need? (30 mins)
    Loblaw, A.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S550 - S550
  • [43] More nomograms or better lymph node dissection - what do we need in prostate cancer?
    Spahn, Martin
    BJU INTERNATIONAL, 2015, 116 (05) : 676 - 677
  • [44] SALVAGE RADIATION THERAPY AFTER RECURRENT PROSTATE CANCER: HOW EARLY DO WE NEED TO BE ?
    Muller, Roberto
    Moreira, Daniel
    Aronson, William
    Terris, Martha
    Kane, Christopher
    Amling, Christopher
    Presti, Joseph, Jr.
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2013, 189 (04): : E295 - E296
  • [45] Do we need pharmacological therapy for atrial fibrillation in the ablation era?
    Samuel Lévy
    Journal of Interventional Cardiac Electrophysiology, 2006, 17 : 189 - 194
  • [46] Do we need pharmacological therapy for atrial fibrillation in the ablation era?
    Levy, Samuel
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2006, 17 (03) : 189 - 194
  • [47] From New Targets to New Drugs in Prostate Cancer - Other Targets
    Chi, K. N.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S61 - S61
  • [48] PSMA-PET for Lymph Node Detection in Recurrent Prostate Cancer: How do we use the Magic Bullet?
    Maurer, Tobias
    Murphy, Declan G.
    Hofman, Michael S.
    Eiber, Matthias
    THERANOSTICS, 2017, 7 (07): : 2046 - 2047
  • [49] SPEAKING TO PATIENTS WITH PROSTATE CANCER: ARE WE MEETING THE NEED?
    Kaiser, Amy
    Kaiser, Amy
    Chestnut, Emma
    Chestnut, Emma
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [50] Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET
    Sabbagh, Ali
    Mohamad, Osama
    Lichter, Katie E.
    Hope, Thomas A.
    CANCERS, 2022, 14 (24)